Edwards Lifesciences Corp (EW)

Finanzdaten der Edwards Lifesciences Corp-Aktie (EW)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.60%1,741.00	1,648.60	1,569.60	1,553.10	1,532.20
Cost Of Revenue	8.22%392.40	362.60	343.00	345.20	344.40
Gross Profit	4.87%1,348.60	1,286.00	1,226.60	1,207.90	1,187.80
	7.47%561.20	522.20	-	-	-
Selling, General, and Administrative	7.47%561.20	522.20	-	-	-
Research and Development	5.92%278.90	263.30	-	-	-
Operating Income/Loss	7.45%513.20	477.60	151.10	307.10	411.20
Net Interest Income/Expense	10.45%30.00	33.50	-132.90	38.60	37.40
Nonoperating Income/Loss	135.48%6.60	-18.60	-60.70	41.30	-11.00
Income/Loss From Continuing Operations Before Tax	13.25%519.80	459.00	90.40	348.40	400.20
Income Tax Expense/Benefit	255.56%278.40	78.30	26.20	56.10	64.30
Income/Loss From Continuing Operations After Tax	36.59%241.40	380.70	64.20	292.30	335.90
Income/Loss From Discontinued Operations, Net Of Tax	-	-	27.00	-2.00	-4.40
	36.59%241.40	380.70	91.20	290.30	331.50
Attributable To Parent	36.46%241.90	380.70	91.20	291.10	333.20
Attributable To Noncontrolling Interest	-0.50	-	-	-0.80	-1.70
Basic Average Shares	0.48%576.40	579.20	-1.40	584.70	587.00
Diluted Average Shares	0.53%577.60	580.70	-1.40	585.70	587.90
Basic Earnings Per Share	36.36%0.42	0.66	0.16	0.50	0.57
Diluted Earnings Per Share	36.36%0.42	0.66	0.16	0.50	0.56